The right choice depends on your full health picture, not just trial numbers
Often this means: Slowing the rate of weight loss Increasing protein intake Repleting deficiencies Supporting lean mass preservation Addressing hormonal contributors In select patients, additional therapies such as PRF, topical growth stimulants, or medical hair restoration protocols may be appropriate
Ozempic and Wegovy, powered by semaglutide, and Mounjaro, based on tirzepatide, have captured global attention
Depending on the patient, monitoring may include: Weight trends Waist circumference Blood pressure Glucose and A1C Lipids Liver markers Kidney markers Thyroid markers when appropriate Nutrient markers when indicated Hormone considerations when relevant Adjust the Plan as the Body Changes A patients needs at the start of treatment may not be the same after losing 20, 40, or 60 pounds
falciparum growth by measuring their IC 50 values in vitro ( Figure 5 and Table 2 )